ATTD-ASIA Clinical Innovation Award Winner

Dr. Amit Gupta Wins the ATTD-ASIA Clinical Innovation Award for Groundbreaking Advances in Diabetes Care

December 2025 – ATTD-ASIA, Singapore

The ATTD-ASIA Clinical Innovation Award, presented by ATTD-ASIA and Eli Lilly and Company, is proud to announce Dr. Amit Gupta as the winner for his pioneering work in digital health innovation. Dr. Gupta, a renowned diabetes expert and Chair of the IDF School of Diabetes and Education Committee, is being recognized for his leadership in advancing AI-driven solutions in diabetes management.

As the Chief AI & Clinical Innovation Advisor at Tap Health, Dr. Gupta has spearheaded the development of a fully autonomous digital therapeutic for type 2 diabetes. This cutting-edge platform offers a real-time AI companion for patients, allowing for continuous monitoring and personalized interventions between clinic visits at just one-tenth of the cost of traditional human-led care. Tap Health’s adaptive engine leverages data from lifestyle patterns, glucose trajectories, and behavioral inputs to provide predictive, tailored solutions that strengthen patient adherence and significantly improve glycemic outcomes.

The ATTD-ASIA Clinical Innovation Award is presented to innovators who demonstrate exceptional contributions to improving the clinical practice of diabetes care. Dr. Gupta’s work aligns perfectly with the award’s criteria, emphasizing patient-centered innovation, clinical impact, and scalability. As part of his recognition, Dr. Gupta will receive a €10,000 professional development grant, a travel grant to attend ATTD-ASIA, and the opportunity to share his work at the conference in December.